////////////////
Drug discovery is broken.
Katamaran is fixing it.
Combining patient derived tumoroids, automation, and generative AI design, Katamaran’s AI powered super engine revives dormant science to create life saving cancer drugs faster and for more people.
Developing a single therapy can take a decade and billions of dollars, slowed by outdated cell line and animal models, along with narrowly focused trials that overlook much of the world’s genetic diversity.
Cancer still claims 10 million lives every year, while thousands of promising molecules gather dust.
By accelerating discovery and broadening access, we transform hidden potential into therapies that reach everyone, everywhere.
50,000,000+
By the numbers
50,000,000+
people worldwide are living with cancer today
9700+
18
10-12
$200K vs. $60K
deaths every year-roughly one in six global deaths
lives lost every minute.
years to bring drug to the market
per year advanced drug costs:
(Developed nations vs India)
35,000,000+
95%
Cases per year projected by 2036
Oncology drug candidates fail in clinical trails
Our solution
Precision medicine, powered by human relevant data
Katamaran integrates generative AI, patient derived tumoroids and robotic automation labs to leapfrog guess and wait oncology R&D. We design, test, and iterate directly on human biology from day one, dramatically reducing timelines and costs so breakthrough cancer therapies reach patients faster.
70%
6x
2x
cost reduction
faster lead development
higher success odds
Generative models forecast the best-fit targets
Predict
*Modeled against conventional workflows; based on internal data and published benchmarks.
Tumoroids confirm human relevance
Validate
Robotics automation compress months of lab work into days
Scale
70%
6x
cost reduction
faster lead development
higher success odds
2x
Wet Lab
Wet Lab
We leverage biomedical research to design innovative drugs , diagnostic tools, and scalable healthtech solutions tailored for global impact.
Computational Lab
Our AI-powered platforms enable predictive modeling, precision diagnostics, and data-driven drug development at unprecedented speed and scale.
We leverage biomedical research to design innovative drugs , diagnostic tools, and scalable healthtech solutions tailored for global impact.
Through smart engineering and automated platforms, we enhance reproducibility, reduce costs, and accelerate innovation across all our ventures.
Our R&D and Pipeline
////////////////
////////////////
+
+
+
Company and Team
“Our platform is engineered to cut development costs by up to two-thirds, accelerate lead selection six fold, and because we validate on patient-derived tumoroids double the odds a therapy reaches the clinic.”
- Arun Asaithambi, Ph.D. Founder
Arun Asaithambi, Ph.D.
Founder and CEO
Anand Asaithambi,
Co-Founder
Research labs
+
+
+
October 10, 2017
////////////////
Featured News
April 9, 2024
Aug 1, 2025
October 10, 2017
For more news
October 10, 2017
What Experts Are Saying
“Head and neck cancers are extremely common but low awareness and non-specific symptoms delay diagnosis. When caught early they have excellent cure rates. Precision therapies are becoming more crucial as a one size fits all approach is ineffective.”
-Dr. Narayana Subramaniam
Lead Consultant, Head & Neck Oncology, Aster Hospitals, Bangalore
+
+
+
////////////////
We’re looking for collaborators, investors, and visionary scientists. Reach out and be part of the mission.
Follow Us
© 2025 Katamaran Industries. Innovating for global health equity.
Quick Links
Our Address
India :
Unit, #603, 6th floor, Sigmasoft tech park, Gamma block, Whitefeild, Bengaluru, Karnataka, 560066
US :
Unit 419,180 talmadge rd, Edison nj 08817
UK :
41 Clooney Terrace, Londonderry, Northern Ireland, BT47 6AP
